Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
While this updated vaccine has been formulated to target the JN.1 variant, NVAX claims that the vaccine has also been shown to be effective against the current circulating strains, including KP.2 and KP.3. This submission is in line with the EMA's guidance issued on Apr 30, which advised COVID-19 vaccine manufacturers like Moderna MRNA, Novavax, and Pfizer PFE to update their respective COVID-19 vaccines to target the JN.1 variant. Management is working with other regulatory authorities across the globe to secure authorization/approval for updating its protein-based COVID-19 vaccine. Year to date, the stock has skyrocketed 192.1% against the industry's 4.1% fall. Image Source: Zacks Investment Research Novavax's COVID-19 vaccine is only authorized in the European Union (EU) for use in individuals aged 12 years and older. A similar filing was also submitted to the FDA last week, seeking to update its COVID-19 vaccine for the upcoming fall season. Unlike the EMA guidance, w
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- New Covid Shots Recommended for Americans 6 Months and Older This Fall [The New York Times]The New York Times
- Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax (NVAX) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/25/24 - Form 4
- 6/21/24 - Form 4
- 6/20/24 - Form 4
- NVAX's page on the SEC website